Joanne S. Buzaglo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joanne S. Buzaglo has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Mitch Golant
The Wellness Community/Cancer Support Community, Research & Training Institute, Cancer Support Community, 4100 Chamounix Drive, Philadelphia, PA 19131, USA
6 shared publications - Melissa Farmer Miller
Research and Training Institute, Cancer Support Community, Washington, USA
5 shared publications Mitch Golant
Research & Training Institute, Cancer Support Community, Philadelphia, Pennsylvania, USA
4 shared publicationsAnne Morris
Cancer Support Comunity, Research and Training Institute, Philadelphia, PA
3 shared publicationsChristopher Gayer
Research & Training Institute, Cancer Support Community, Philadelphia, Pennsylvania, USA
3 shared publicationsJulie Taylor
Cancer Support Community (CSC) Washington DC USA
3 shared publications
Latest Publications
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e15583
Cancer-related distress and cost of care concerns among gastric cancer patients.
E15583 Background: Individuals with gastric cancer (GC) are at risk for significant physical, psychological, and financial burden related to their illness and cost of care. This study characterizes cancer-related distress and concerns among survivors of GC and related cancers and the support survivors receive from their health care team for these concerns. Methods: Of 110 GC survivors enrolled in the Cancer Support Community’s online Cancer Experience Registry, 30 (43% stomach, 37% esophageal, 20% GIST) rated their level of concern (0 = not at all; 4 = very seriously) about psychological, emotional, physical and practical concerns (27 items). Risk for clinically significant distress was identified via a 4-item subscale (α = 0.86, cutoff score = 6.) Participants also completed the Impact of Events (IES) intrusion subscale and questions about their healthcare team’s involvement in addressing concerns. Results: Participant median age was 61 years; median time since diagnosis was 3 years. 23% experienced recurrence; 37% had metastatic disease.The highest ranked concerns (rated moderately to very seriously) included: eating and nutrition (62%); fatigue (62%); health insurance or money worries (59%); worry about the future (59%); feeling sad or depressed (50%); changes or disruptions to work, school, or home life (48%); sleep problems (48%); and worry about family (48%). Half of respondents (50%) were at risk for clinically significant emotional distress; 39% reported intrusive thoughts about the cost of cancer care. Fewer than half indicated their health care team asked about emotional distress (43%), lifestyle (43%), work (40%), finances (37%), or family (33%). Participants wished for more help with emotions related to cancer (57%), long-term side effects (55%), and financial advice/assistance (52%). Conclusions: Substantial proportions of gastric cancer survivors express concern about physical symptoms, emotional distress, and financial burden, yet many report they are not counseled about these concerns. Efforts are needed to reduce distress and the financial burden associated with gastric cancer to reduce their potential impact on quality of life, treatment adherence, and other illness outcomes.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e15583
Cancer-related distress and cost of care concerns among gastric cancer patients.
E15583 Background: Individuals with gastric cancer (GC) are at risk for significant physical, psychological, and financial burden related to their illness and cost of care. This study characterizes cancer-related distress and concerns among survivors of GC and related cancers and the support survivors receive from their health care team for these concerns. Methods: Of 110 GC survivors enrolled in the Cancer Support Community’s online Cancer Experience Registry, 30 (43% stomach, 37% esophageal, 20% GIST) rated their level of concern (0 = not at all; 4 = very seriously) about psychological, emotional, physical and practical concerns (27 items). Risk for clinically significant distress was identified via a 4-item subscale (α = 0.86, cutoff score = 6.) Participants also completed the Impact of Events (IES) intrusion subscale and questions about their healthcare team’s involvement in addressing concerns. Results: Participant median age was 61 years; median time since diagnosis was 3 years. 23% experienced recurrence; 37% had metastatic disease.The highest ranked concerns (rated moderately to very seriously) included: eating and nutrition (62%); fatigue (62%); health insurance or money worries (59%); worry about the future (59%); feeling sad or depressed (50%); changes or disruptions to work, school, or home life (48%); sleep problems (48%); and worry about family (48%). Half of respondents (50%) were at risk for clinically significant emotional distress; 39% reported intrusive thoughts about the cost of cancer care. Fewer than half indicated their health care team asked about emotional distress (43%), lifestyle (43%), work (40%), finances (37%), or family (33%). Participants wished for more help with emotions related to cancer (57%), long-term side effects (55%), and financial advice/assistance (52%). Conclusions: Substantial proportions of gastric cancer survivors express concern about physical symptoms, emotional distress, and financial burden, yet many report they are not counseled about these concerns. Efforts are needed to reduce distress and the financial burden associated with gastric cancer to reduce their potential impact on quality of life, treatment adherence, and other illness outcomes.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , e18259
Definitions of value among patients with breast cancer.
E18259 Background: Value in health care is the nexus of best care and lowest cost. How patients define value is key to measuring health care value in this era of shared decision making. Very little is understood about how patients define value and how disease stage may influence their attributions of value. We report on how persons diagnosed with metastatic (MBC) and non-metastatic breast cancer (non-MBC) define value. Methods: We asked registrants in the online Cancer Experience Registry: “When considering your cancer experience, how would you define value?” This analysis includes persons diagnosed with breast cancer who answered (n=651), comparing MBC (n=415) to non-MBC (n=236). (MBC response rate = 54%; non-MBC response rate = 49%.) Two researchers coded responses by categories, including: 1) personal benefit, 2) health care benefit. Subcategories are reported in Table 1. Interrater reliability was 90%. Table 1 shows responses by category for MBC and non-MBC. Results: Average age was 57 for MBC patients and 56 for non-MBC patients. Among those with non-MBC, 53% defined value as personal benefit. Among these patients, most defined value as a learned principle (42%; “Live each day to its best”). Findings are similar to patients with MBC for these sub-categories (Table 1). A nearly equal proportion of patients with MBC (28%) and non-MBC (29%) defined value in terms of health. Among those with non-MBC who defined value relative to health (n=68), most (43%) cited relationship with one’s health care team. Conclusions: These findings provide further support that patients may define value differently from HCPs, which may lead to a lack of alignment between HCPs and patients about what matters most in delivery of patient-centered care.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , e18259
Definitions of value among patients with breast cancer.
E18259 Background: Value in health care is the nexus of best care and lowest cost. How patients define value is key to measuring health care value in this era of shared decision making. Very little is understood about how patients define value and how disease stage may influence their attributions of value. We report on how persons diagnosed with metastatic (MBC) and non-metastatic breast cancer (non-MBC) define value. Methods: We asked registrants in the online Cancer Experience Registry: “When considering your cancer experience, how would you define value?” This analysis includes persons diagnosed with breast cancer who answered (n=651), comparing MBC (n=415) to non-MBC (n=236). (MBC response rate = 54%; non-MBC response rate = 49%.) Two researchers coded responses by categories, including: 1) personal benefit, 2) health care benefit. Subcategories are reported in Table 1. Interrater reliability was 90%. Table 1 shows responses by category for MBC and non-MBC. Results: Average age was 57 for MBC patients and 56 for non-MBC patients. Among those with non-MBC, 53% defined value as personal benefit. Among these patients, most defined value as a learned principle (42%; “Live each day to its best”). Findings are similar to patients with MBC for these sub-categories (Table 1). A nearly equal proportion of patients with MBC (28%) and non-MBC (29%) defined value in terms of health. Among those with non-MBC who defined value relative to health (n=68), most (43%) cited relationship with one’s health care team. Conclusions: These findings provide further support that patients may define value differently from HCPs, which may lead to a lack of alignment between HCPs and patients about what matters most in delivery of patient-centered care.
- 20 January 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (3_suppl) , 220
Cancer-related distress and unmet needs among newly diagnosed and longer-term cancer survivors from a community-based distress screening program.
220 Background: As survival rates increase among cancer patients, quality of life needs become more salient. Cancer Support Source (CSS) is a distress screening, referral and follow up program that uses a validated distress screening tool and referral algorithm to link cancer patients to resources tailored to their needs. The objective of this study was to describe psychosocial concerns and unmet needs at different times since cancer diagnosis. Methods: English speaking cancer survivors (n = 905) across 26 affiliates of a nationwide cancer support organization participated in the CSS program by first completing a screening tool, including a 4 item depression subscale. Participants rated the level of concern (0 to 4) about 15 items and identified the help they wanted for each item (talk with a member of your health care team and/or connect you with online resources). We used regression analysis, adjusting for age, to examine differences by time since diagnosis ( < 1 y; ≥ 1 y) in level of distress; type of concerns (rated ≥ 2); and items selected to talk with the health care team. Results: The sample was 78% female, 10% Latino, 9% Black, and median age 57 y. 41% were breast cancer survivors, 6% lung, and 6% colorectal. More than half were within 1 y of their diagnosis (61%, n = 507); 39% ≥ 1 y (n = 331). Those newly diagnosed ( < 1 y) had significantly higher levels of distress (p = 0.011); increased risk for depression (p = 0.007); and more likely to be concerned about changes in work, school, or home life; body image; feeling nervous or afraid; worry about the future; and making a treatment decision (p < 0.05). Among those who indicated that an item was a concern, newly diagnosed patients were significantly more likely to want to talk to their health care team about pain; financial worries; exercising; feeling lonely or isolated; feeling nervous or afraid; and worry about the future (p < 0.05). Conclusions: These findings suggest that patients are more distressed and more likely to want to talk about their psychosocial needs within the first year of a cancer diagnosis. Future research should evaluate efforts to provide tailored resources within the first year of a diagnosis when distress levels are highest.
- 20 January 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (3_suppl) , 220
Cancer-related distress and unmet needs among newly diagnosed and longer-term cancer survivors from a community-based distress screening program.
220 Background: As survival rates increase among cancer patients, quality of life needs become more salient. Cancer Support Source (CSS) is a distress screening, referral and follow up program that uses a validated distress screening tool and referral algorithm to link cancer patients to resources tailored to their needs. The objective of this study was to describe psychosocial concerns and unmet needs at different times since cancer diagnosis. Methods: English speaking cancer survivors (n = 905) across 26 affiliates of a nationwide cancer support organization participated in the CSS program by first completing a screening tool, including a 4 item depression subscale. Participants rated the level of concern (0 to 4) about 15 items and identified the help they wanted for each item (talk with a member of your health care team and/or connect you with online resources). We used regression analysis, adjusting for age, to examine differences by time since diagnosis ( < 1 y; ≥ 1 y) in level of distress; type of concerns (rated ≥ 2); and items selected to talk with the health care team. Results: The sample was 78% female, 10% Latino, 9% Black, and median age 57 y. 41% were breast cancer survivors, 6% lung, and 6% colorectal. More than half were within 1 y of their diagnosis (61%, n = 507); 39% ≥ 1 y (n = 331). Those newly diagnosed ( < 1 y) had significantly higher levels of distress (p = 0.011); increased risk for depression (p = 0.007); and more likely to be concerned about changes in work, school, or home life; body image; feeling nervous or afraid; worry about the future; and making a treatment decision (p < 0.05). Among those who indicated that an item was a concern, newly diagnosed patients were significantly more likely to want to talk to their health care team about pain; financial worries; exercising; feeling lonely or isolated; feeling nervous or afraid; and worry about the future (p < 0.05). Conclusions: These findings suggest that patients are more distressed and more likely to want to talk about their psychosocial needs within the first year of a cancer diagnosis. Future research should evaluate efforts to provide tailored resources within the first year of a diagnosis when distress levels are highest.
- 1 March 2015
- Published by Frontline Medical Communications, Inc. in The Journal of Community and Supportive Oncology
- Vol. 13 (3) , 104-112
The need for decision and communication aids: a survey of breast cancer survivors
Background Qualitative studies have identified barriers to communication and informed decision making among breast cancer survivors making treatment decisions. The prevalence of these barriers is unknown. Objective To quantify the need for decision support among breast cancer survivors. Methods We surveyed 2,521 breast cancer survivors participating in an online registry hosted by the Cancer Support Community to find out what proportion of breast cancer patients: made decisions during their first visit with a specialist; received satisfactory information before that visit; asked questions an...
- 1 March 2015
- Published by Frontline Medical Communications, Inc. in The Journal of Community and Supportive Oncology
- Vol. 13 (3) , 104-112
The need for decision and communication aids: a survey of breast cancer survivors
Background Qualitative studies have identified barriers to communication and informed decision making among breast cancer survivors making treatment decisions. The prevalence of these barriers is unknown. Objective To quantify the need for decision support among breast cancer survivors. Methods We surveyed 2,521 breast cancer survivors participating in an online registry hosted by the Cancer Support Community to find out what proportion of breast cancer patients: made decisions during their first visit with a specialist; received satisfactory information before that visit; asked questions an...
- 10 September 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (26_suppl) , 118
Cancer-related distress and unmet needs among members of a metastatic breast cancer registry.
118 Background: An estimated 155,000 people are living with metastatic breast cancer (MBC) in the US. Emotional distress among people living with MBC is common; yet, little is known about the patient experience and distress screening. Methods: Since March 2013, the Cancer Support Community has registered 909 people living with MBC to the Cancer Experience Registry, an online initiative that is designed to raise awareness about the psychosocial impact of cancer. 599 registrants responded to questions about cancer related distress. This sample was 99% female, 91% Caucasian, and 69% with a college degree and median age 56. Median time since MBC diagnosis was 3 years. Results: The top sources of distress (% rated seriously or very seriously concerned) were: (1) worry about the future (44%); (2) fatigue (39%); (3) health insurance or money worries (38%). 49% reported fatigue was ‘quite a bit’ or ‘very much’ disruptive in their life and 46% reported intrusive ideation about the financial cost of care. Factors that were independently associated with greater overall distress included younger age (p<0.001), higher comorbidity (p<0.001), lower income (p=0.001). 43% of respondents were never asked about distress by their health care team. Those who received all or part of their treatment in an academic or comprehensive cancer center were significantly more likely to be asked about distress versus those receiving treatment anywhere else (65% vs. 50%, p=0.002). Among those who were asked about distress (n=340), 62% received referrals to manage distress within their health care system, and 19% at a community-based organization; 47% reported their health care team helped coordinated distress-related care. 20% of those asked about distress never received referrals for managing it. Conclusions: These findings support the need for integrated supportive care services and better side-effect management. Disturbingly, 20% of patients who asked for referrals never received them and only 19% of patients were referred to community-based organizations for treating their distress where these services are often provided at low or no-cost. There is an on-going need for coordinated care that integrates programs and services across health care systems.
- 10 September 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (26_suppl) , 118
Cancer-related distress and unmet needs among members of a metastatic breast cancer registry.
118 Background: An estimated 155,000 people are living with metastatic breast cancer (MBC) in the US. Emotional distress among people living with MBC is common; yet, little is known about the patient experience and distress screening. Methods: Since March 2013, the Cancer Support Community has registered 909 people living with MBC to the Cancer Experience Registry, an online initiative that is designed to raise awareness about the psychosocial impact of cancer. 599 registrants responded to questions about cancer related distress. This sample was 99% female, 91% Caucasian, and 69% with a college degree and median age 56. Median time since MBC diagnosis was 3 years. Results: The top sources of distress (% rated seriously or very seriously concerned) were: (1) worry about the future (44%); (2) fatigue (39%); (3) health insurance or money worries (38%). 49% reported fatigue was ‘quite a bit’ or ‘very much’ disruptive in their life and 46% reported intrusive ideation about the financial cost of care. Factors that were independently associated with greater overall distress included younger age (p<0.001), higher comorbidity (p<0.001), lower income (p=0.001). 43% of respondents were never asked about distress by their health care team. Those who received all or part of their treatment in an academic or comprehensive cancer center were significantly more likely to be asked about distress versus those receiving treatment anywhere else (65% vs. 50%, p=0.002). Among those who were asked about distress (n=340), 62% received referrals to manage distress within their health care system, and 19% at a community-based organization; 47% reported their health care team helped coordinated distress-related care. 20% of those asked about distress never received referrals for managing it. Conclusions: These findings support the need for integrated supportive care services and better side-effect management. Disturbingly, 20% of patients who asked for referrals never received them and only 19% of patients were referred to community-based organizations for treating their distress where these services are often provided at low or no-cost. There is an on-going need for coordinated care that integrates programs and services across health care systems.
- 26 June 2014
- Published by Springer Nature in Quality of Life Research
- Vol. 23 (10) , 2855-2863
Discriminatory power of a 25-item distress screening tool: a cross-sectional survey of 251 cancer survivors
The objective was to test the discriminatory power of a 25-item distress screening tool for use among cancer survivors. We used a measure of item discrimination to determine which items perform better than others at identifying those at greatest risk of distress.
- 26 June 2014
- Published by Springer Nature in Quality of Life Research
- Vol. 23 (10) , 2855-2863
Discriminatory power of a 25-item distress screening tool: a cross-sectional survey of 251 cancer survivors
The objective was to test the discriminatory power of a 25-item distress screening tool for use among cancer survivors. We used a measure of item discrimination to determine which items perform better than others at identifying those at greatest risk of distress.
- 1 January 2014
- Published by Frontline Medical Communications, Inc. in The Journal of Community and Supportive Oncology
- Vol. 12 (1) , 6-12
Understanding the experience of living with non–small-cell lung cancer (NSCLC): a qualitative study
Background As non–small-cell lung cancer (NSCLC) treatments improve and patients live longer, it is important to develop interventions to help patients live fuller lives.
- 1 January 2014
- Published by Frontline Medical Communications, Inc. in The Journal of Community and Supportive Oncology
- Vol. 12 (1) , 6-12
Understanding the experience of living with non–small-cell lung cancer (NSCLC): a qualitative study
Background As non–small-cell lung cancer (NSCLC) treatments improve and patients live longer, it is important to develop interventions to help patients live fuller lives.
- 18 November 2013
- Published by SAGE Publications in Medical Decision Making
- Vol. 34 (4) , 454-463
Knowledge, Attitudes, and Self-efficacy as Predictors of Preparedness for Oncology Clinical Trials
Objective. This study used the Ottawa Decision Support Framework to evaluate a model examining associations between clinical trial knowledge, attitudinal barriers to participating in clinical trials, clinical trial self-efficacy, and clinical trial preparedness among 1256 cancer patients seen for their first outpatient consultation at a cancer center. As an exploratory aim, moderator effects for gender, race/ethnicity, education, and metastatic status on associations in the model were evaluated. Methods. Patients completed measures of cancer clinical trial knowledge, attitudinal barriers, self-efficacy, and preparedness. Structural equation modeling (SEM) was conducted to evaluate whether self-efficacy mediated the association between knowledge and barriers with preparedness. Results. The SEM explained 26% of the variance in cancer clinical trial preparedness. Self-efficacy mediated the associations between attitudinal barriers and preparedness, but self-efficacy did not mediate the knowledge-preparedness relationship. Conclusions. Findings partially support the Ottawa Decision Support Framework and suggest that assessing patients’ level of self-efficacy may be just as important as evaluating their knowledge and attitudes about cancer clinical trials.
- 18 November 2013
- Published by SAGE Publications in Medical Decision Making
- Vol. 34 (4) , 454-463
Knowledge, Attitudes, and Self-efficacy as Predictors of Preparedness for Oncology Clinical Trials
Objective. This study used the Ottawa Decision Support Framework to evaluate a model examining associations between clinical trial knowledge, attitudinal barriers to participating in clinical trials, clinical trial self-efficacy, and clinical trial preparedness among 1256 cancer patients seen for their first outpatient consultation at a cancer center. As an exploratory aim, moderator effects for gender, race/ethnicity, education, and metastatic status on associations in the model were evaluated. Methods. Patients completed measures of cancer clinical trial knowledge, attitudinal barriers, self-efficacy, and preparedness. Structural equation modeling (SEM) was conducted to evaluate whether self-efficacy mediated the association between knowledge and barriers with preparedness. Results. The SEM explained 26% of the variance in cancer clinical trial preparedness. Self-efficacy mediated the associations between attitudinal barriers and preparedness, but self-efficacy did not mediate the knowledge-preparedness relationship. Conclusions. Findings partially support the Ottawa Decision Support Framework and suggest that assessing patients’ level of self-efficacy may be just as important as evaluating their knowledge and attitudes about cancer clinical trials.
- 27 June 2012
- Published by Wiley in Psycho-Oncology
- Vol. 22 (6) , 1249-1257
Demonstrating the psychometric properties of a problem‐related distress screener in a community sample of 319 cancer survivors
Objective: The purpose was to test the psychometric properties of a 36‐item community‐based problem‐related distress screening tool, among 319 cancer survivors recruited across 14 affiliates of the Cancer Support Community.Methods: Internal reliability was estimated using Cronbach's alpha coefficient. Test–retest reliability was assessed using the intra‐class correlation coefficient (ICC). Concurrent validity was determined by correlations with the Functional Assessment of Cancer Therapy‐General Well‐Being Scale (FACT‐G), the Center for Epidemiologic Studies Depression Scale (CES‐D), and the Distress Thermometer (DT) and receiver operating characteristic (ROC) curve analysis using the CES‐D (≥16) and DT (≥4) as the criterion. Non‐parametric analysis of variance was used to establish discriminant validity.Results: The distress screener demonstrated high internal consistency (Cronbach's alpha = 0.91) and strong test–retest reliability (ICC ≥ 0.75). Summary scores of the distress screener correlated substantially with the FACT‐G (R2 = 0.58, p < 0.001), CES‐D (R2 = 0.48, p < 0.001), and DT (R2 = 0.35, p < 0.001) indicating strong concurrent validity and were able to discriminate groups of clinical relevance. ROC analyses showed a cutoff score of 8 for problem items rated ≥3 had optimal sensitivity and specificity relative to the CES‐D and DT.Conclusions: The distress screener shows strong psychometric properties and can be considered a valuable community‐based instrument to screen for psychological distress related to social, emotional, physical, and other patient‐related symptoms and problems. This study is the first to address the chasm between hospital and community‐based screening by validating a community‐based instrument and has begun to demonstrate the feasibility of screening in the community. Copyright © 2012 John Wiley & Sons, Ltd.
- 27 June 2012
- Published by Wiley in Psycho-Oncology
- Vol. 22 (6) , 1249-1257
Demonstrating the psychometric properties of a problem‐related distress screener in a community sample of 319 cancer survivors
Objective: The purpose was to test the psychometric properties of a 36‐item community‐based problem‐related distress screening tool, among 319 cancer survivors recruited across 14 affiliates of the Cancer Support Community.Methods: Internal reliability was estimated using Cronbach's alpha coefficient. Test–retest reliability was assessed using the intra‐class correlation coefficient (ICC). Concurrent validity was determined by correlations with the Functional Assessment of Cancer Therapy‐General Well‐Being Scale (FACT‐G), the Center for Epidemiologic Studies Depression Scale (CES‐D), and the Distress Thermometer (DT) and receiver operating characteristic (ROC) curve analysis using the CES‐D (≥16) and DT (≥4) as the criterion. Non‐parametric analysis of variance was used to establish discriminant validity.Results: The distress screener demonstrated high internal consistency (Cronbach's alpha = 0.91) and strong test–retest reliability (ICC ≥ 0.75). Summary scores of the distress screener correlated substantially with the FACT‐G (R2 = 0.58, p < 0.001), CES‐D (R2 = 0.48, p < 0.001), and DT (R2 = 0.35, p < 0.001) indicating strong concurrent validity and were able to discriminate groups of clinical relevance. ROC analyses showed a cutoff score of 8 for problem items rated ≥3 had optimal sensitivity and specificity relative to the CES‐D and DT.Conclusions: The distress screener shows strong psychometric properties and can be considered a valuable community‐based instrument to screen for psychological distress related to social, emotional, physical, and other patient‐related symptoms and problems. This study is the first to address the chasm between hospital and community‐based screening by validating a community‐based instrument and has begun to demonstrate the feasibility of screening in the community. Copyright © 2012 John Wiley & Sons, Ltd.